Skip to main content
Top
Published in: Medical Microbiology and Immunology 3/2020

Open Access 01-06-2020 | Yersina Enterocolitica | Review

Immunogenicity of trimeric autotransporter adhesins and their potential as vaccine targets

Authors: Arno Thibau, Alexander A. Dichter, Diana J. Vaca, Dirk Linke, Adrian Goldman, Volkhard A. J. Kempf

Published in: Medical Microbiology and Immunology | Issue 3/2020

Login to get access

Abstract

The current problem of increasing antibiotic resistance and the resurgence of numerous infections indicate the need for novel vaccination strategies more than ever. In vaccine development, the search for and the selection of adequate vaccine antigens is the first important step. In recent years, bacterial outer membrane proteins have become of major interest, as they are the main proteins interacting with the extracellular environment. Trimeric autotransporter adhesins (TAAs) are important virulence factors in many Gram-negative bacteria, are localised on the bacterial surface, and mediate the first adherence to host cells in the course of infection. One example is the Neisseria adhesin A (NadA), which is currently used as a subunit in a licensed vaccine against Neisseria meningitidis. Other TAAs that seem promising vaccine candidates are the Acinetobacter trimeric autotransporter (Ata), the Haemophilus influenzae adhesin (Hia), and TAAs of the genus Bartonella. Here, we review the suitability of various TAAs as vaccine candidates.
Literature
11.
go back to reference Michalik M, Djahanshiri B, Leo JC, Linke D (2016) Reverse vaccinology: the pathway from genomes and epitope predictions to tailored recombinant vaccines. In: Thomas S (ed) Vaccine design: methods and protocols, vol 1. vaccines for human diseases. Springer New York, New York, pp 87–106. https://doi.org/10.1007/978-1-4939-3387-7_4 CrossRef Michalik M, Djahanshiri B, Leo JC, Linke D (2016) Reverse vaccinology: the pathway from genomes and epitope predictions to tailored recombinant vaccines. In: Thomas S (ed) Vaccine design: methods and protocols, vol 1. vaccines for human diseases. Springer New York, New York, pp 87–106. https://​doi.​org/​10.​1007/​978-1-4939-3387-7_​4 CrossRef
17.
go back to reference Qin W, Wang L, Zhai R et al (2016) Trimeric autotransporter adhesins contribute to Actinobacillus pleuropneumoniae pathogenicity in mice and regulate bacterial gene expression during interactions between bacteria and porcine primary alveolar macrophages. Antonie Van Leeuwenhoek 109:51–70. https://doi.org/10.1007/s10482-015-0609-x CrossRefPubMed Qin W, Wang L, Zhai R et al (2016) Trimeric autotransporter adhesins contribute to Actinobacillus pleuropneumoniae pathogenicity in mice and regulate bacterial gene expression during interactions between bacteria and porcine primary alveolar macrophages. Antonie Van Leeuwenhoek 109:51–70. https://​doi.​org/​10.​1007/​s10482-015-0609-x CrossRefPubMed
20.
go back to reference Cordwell SJ, Nouwens AS (2004) Proteome analysis of outer membrane and extracellular proteins from Pseudomonas aeruginosa for vaccine discovery. In: Grandi G (ed) Genomics Proteomics and Vaccines. Wiley, Chichester, England, pp 285–304 Cordwell SJ, Nouwens AS (2004) Proteome analysis of outer membrane and extracellular proteins from Pseudomonas aeruginosa for vaccine discovery. In: Grandi G (ed) Genomics Proteomics and Vaccines. Wiley, Chichester, England, pp 285–304
22.
go back to reference Casadevall A, Pirofski L (1999) Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun 67:3703 (LP – 3713) CrossRefPubMedPubMedCentral Casadevall A, Pirofski L (1999) Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun 67:3703 (LP – 3713) CrossRefPubMedPubMedCentral
59.
go back to reference Van Alphen L, Riemens T, Poolman J, Zanen HC (1983) Characteristics of major outer membrane proteins of Haemophilus influenzae. J Bacteriol 155:878 (LP – 885) CrossRefPubMedPubMedCentral Van Alphen L, Riemens T, Poolman J, Zanen HC (1983) Characteristics of major outer membrane proteins of Haemophilus influenzae. J Bacteriol 155:878 (LP – 885) CrossRefPubMedPubMedCentral
65.
go back to reference Aebi C, Lafontaine ER, Cope LD et al (1998) Phenotypic effect of isogenic UspA1 and UspA2 mutations on Moraxella catarrhalis 035E. Infect Immun 66:3113 (LP – 3119) CrossRefPubMedPubMedCentral Aebi C, Lafontaine ER, Cope LD et al (1998) Phenotypic effect of isogenic UspA1 and UspA2 mutations on Moraxella catarrhalis 035E. Infect Immun 66:3113 (LP – 3119) CrossRefPubMedPubMedCentral
76.
go back to reference Noll A, Autenrieth IB (1996) Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12. Infect Immun 64:2955 (LP – 2961) CrossRefPubMedPubMedCentral Noll A, Autenrieth IB (1996) Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12. Infect Immun 64:2955 (LP – 2961) CrossRefPubMedPubMedCentral
80.
go back to reference Bölin I, Wolf-Watz H (1984) Molecular cloning of the temperature-inducible outer membrane protein 1 of Yersinia pseudotuberculosis. Infect Immun 43:72 (LP – 78) CrossRefPubMedPubMedCentral Bölin I, Wolf-Watz H (1984) Molecular cloning of the temperature-inducible outer membrane protein 1 of Yersinia pseudotuberculosis. Infect Immun 43:72 (LP – 78) CrossRefPubMedPubMedCentral
82.
go back to reference Bölin I, Norlander L, Wolf-Watz H (1982) Temperature-inducible outer membrane protein of Yersinia pseudotuberculosis and Yersinia enterocolitica is associated with the virulence plasmid. Infect Immun 37:506 (LP – 512) CrossRefPubMedPubMedCentral Bölin I, Norlander L, Wolf-Watz H (1982) Temperature-inducible outer membrane protein of Yersinia pseudotuberculosis and Yersinia enterocolitica is associated with the virulence plasmid. Infect Immun 37:506 (LP – 512) CrossRefPubMedPubMedCentral
83.
go back to reference Portnoy DA, Moseley SL, Falkow S (1981) Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect Immun 31:775 (LP – 782) CrossRefPubMedPubMedCentral Portnoy DA, Moseley SL, Falkow S (1981) Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect Immun 31:775 (LP – 782) CrossRefPubMedPubMedCentral
85.
go back to reference Han YW, Miller VL (1997) Reevaluation of the virulence phenotype of the inv yadA double mutants of Yersinia pseudotuberculosis. Infect Immun 65:327 (LP – 330) CrossRefPubMedPubMedCentral Han YW, Miller VL (1997) Reevaluation of the virulence phenotype of the inv yadA double mutants of Yersinia pseudotuberculosis. Infect Immun 65:327 (LP – 330) CrossRefPubMedPubMedCentral
87.
go back to reference Roggenkamp A, Ruckdeschel K, Leitritz L et al (1996) Deletion of amino acids 29 to 81 in adhesion protein YadA of Yersinia enterocolitica serotype O:8 results in selective abrogation of adherence to neutrophils. Infect Immun 64:2506CrossRefPubMedPubMedCentral Roggenkamp A, Ruckdeschel K, Leitritz L et al (1996) Deletion of amino acids 29 to 81 in adhesion protein YadA of Yersinia enterocolitica serotype O:8 results in selective abrogation of adherence to neutrophils. Infect Immun 64:2506CrossRefPubMedPubMedCentral
92.
go back to reference Sory MP, Tollenaere J, Laszlo C et al (1990) Detection of pYV + Yersinia enterocolitica isolates by P1 slide agglutination. J Clin Microbiol 28:2403 (LP – 2408) CrossRefPubMedPubMedCentral Sory MP, Tollenaere J, Laszlo C et al (1990) Detection of pYV + Yersinia enterocolitica isolates by P1 slide agglutination. J Clin Microbiol 28:2403 (LP – 2408) CrossRefPubMedPubMedCentral
101.
go back to reference Tikhomirov E, Santamaria M, Esteves K (1997) Meningococcal disease: public health burden and control. World Health Stat Q 50:170–177PubMed Tikhomirov E, Santamaria M, Esteves K (1997) Meningococcal disease: public health burden and control. World Health Stat Q 50:170–177PubMed
106.
go back to reference Finne J, Bitter-Suermann D, Goridis C, Finne U (1987) An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol 138:4402 (LP – 4407) PubMed Finne J, Bitter-Suermann D, Goridis C, Finne U (1987) An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol 138:4402 (LP – 4407) PubMed
110.
go back to reference Tavano R, Franzoso S, Cecchini P et al (2009) The membrane expression of Neisseria meningitidis adhesin A (NadA) increases the proimmune effects of MenB OMVs on human macrophages, compared with NadA–OMVs, without further stimulating their proinflammatory activity on circulating monocytes. J Leukoc Biol 86:143–153. https://doi.org/10.1189/jlb.0109030 CrossRefPubMed Tavano R, Franzoso S, Cecchini P et al (2009) The membrane expression of Neisseria meningitidis adhesin A (NadA) increases the proimmune effects of MenB OMVs on human macrophages, compared with NadA–OMVs, without further stimulating their proinflammatory activity on circulating monocytes. J Leukoc Biol 86:143–153. https://​doi.​org/​10.​1189/​jlb.​0109030 CrossRefPubMed
133.
go back to reference St. Geme JW, Kumar VV, Cutter D, Barenkamp SJ (1998) Prevalence and distribution of the hmw and hia genes and the HMW and Hia adhesins among genetically diverse strains of nontypeable Haemophilus influenzae. Infect Immun 66:364 (LP – 368) CrossRef St. Geme JW, Kumar VV, Cutter D, Barenkamp SJ (1998) Prevalence and distribution of the hmw and hia genes and the HMW and Hia adhesins among genetically diverse strains of nontypeable Haemophilus influenzae. Infect Immun 66:364 (LP – 368) CrossRef
135.
go back to reference Peltola H, Käythy H, Sivonen A, Mäkelä PH (1977) Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 60:730 (LP – 737) PubMed Peltola H, Käythy H, Sivonen A, Mäkelä PH (1977) Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 60:730 (LP – 737) PubMed
153.
go back to reference Bagozzi D, Lindmeier C (2019) In the face of slow progress, WHO offers a new tool and sets a target to accelerate action against antimicrobial resistance. WHO Newsl Bagozzi D, Lindmeier C (2019) In the face of slow progress, WHO offers a new tool and sets a target to accelerate action against antimicrobial resistance. WHO Newsl
154.
go back to reference Davies L O, Bennett S (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. WHO Newsl 7 Davies L O, Bennett S (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. WHO Newsl 7
172.
go back to reference Cope LD, Lafontaine ER, Slaughter CA et al (1999) Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products. J Bacteriol 181:4026–4034CrossRefPubMedPubMedCentral Cope LD, Lafontaine ER, Slaughter CA et al (1999) Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products. J Bacteriol 181:4026–4034CrossRefPubMedPubMedCentral
173.
go back to reference Chen D, McMichael JC, VanDerMeid KR et al (1996) Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect Immun 64:1900–1905CrossRefPubMedPubMedCentral Chen D, McMichael JC, VanDerMeid KR et al (1996) Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect Immun 64:1900–1905CrossRefPubMedPubMedCentral
223.
go back to reference Scherer DC, DeBuron-Connors I, Minnick MF (1993) Characterization of Bartonella bacilliformis flagella and effect of antiflagellin antibodies on invasion of human erythrocytes. Infect Immun 61:4962–4971CrossRefPubMedPubMedCentral Scherer DC, DeBuron-Connors I, Minnick MF (1993) Characterization of Bartonella bacilliformis flagella and effect of antiflagellin antibodies on invasion of human erythrocytes. Infect Immun 61:4962–4971CrossRefPubMedPubMedCentral
224.
go back to reference Howe C, Hertig M (1943) Prophylactic immunization against Carrión’s disease. J Immunol 47:471–482 Howe C, Hertig M (1943) Prophylactic immunization against Carrión’s disease. J Immunol 47:471–482
243.
251.
go back to reference Lattanzi M, Rappuoli R (2005) Vaccination: past, present and future. In: Genomics, proteomics and vaccines. Wiley, Chichester, UK, pp 1–22 Lattanzi M, Rappuoli R (2005) Vaccination: past, present and future. In: Genomics, proteomics and vaccines. Wiley, Chichester, UK, pp 1–22
252.
go back to reference Plotkin SL, Plotkin SA (2013) A short history of vaccination. In: Vaccines. Elsevier, pp 1–13 Plotkin SL, Plotkin SA (2013) A short history of vaccination. In: Vaccines. Elsevier, pp 1–13
Metadata
Title
Immunogenicity of trimeric autotransporter adhesins and their potential as vaccine targets
Authors
Arno Thibau
Alexander A. Dichter
Diana J. Vaca
Dirk Linke
Adrian Goldman
Volkhard A. J. Kempf
Publication date
01-06-2020
Publisher
Springer Berlin Heidelberg
Published in
Medical Microbiology and Immunology / Issue 3/2020
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-019-00649-y

Other articles of this Issue 3/2020

Medical Microbiology and Immunology 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine